GHRH Analogues
CJC-1295 no DAC / Modified GRF (1-29)
A short-acting modified GHRH (1-29) analogue commonly marketed as CJC-1295 no DAC; distinct from albumin-binding CJC-1295 with DAC.
- Investigational
- GHRH Analogue
- WADA Prohibited
Compound dossiers
Identity, receptor pathway, human evidence, safety context, approval history, and unresolved questions.
GHRH Analogues
Sermorelin
- Historical Approval
- GHRH Analogue
- Human Studies
- WADA Prohibited
GHRH Analogues
CJC-1295
- Investigational
- GHRH Analogue
- Human Studies
- WADA Prohibited